Why not change classical treatments for glioblastoma in elderly patients?

doi:10.5493/wjem.v3.i4.50

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 3, Issue 4

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6694)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series.

Item

Count

PDF

460

HTML

3902

Figures (1-1)

Sum=4430

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1344

Download

920

Sum=2264

Nov 20, 2013 (publication date) through Apr 20, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Experimental Medicine

ISSN

2220-315x

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Exp Med. Nov 20, 2013; 3(4): 50-55
Published online Nov 20, 2013. doi: 10.5493/wjem.v3.i4.50

Why not change classical treatments for glioblastoma in elderly patients?

Eduardo Perez-Campos, Javier Arjona Perez, Laura Perez-Campos Mayoral, Itandehui Gallegos Velasco, Pedro Hernandez Cruz, Primitivo Gonzalez Olivera

Eduardo Perez-Campos, Department of Biochemistry and Immunology, Technological Institute of Oaxaca, Oaxaca, CP 68030, Mexico

Eduardo Perez-Campos, Laura Perez-Campos Mayoral, Primitivo Gonzalez Olivera, Primitivo Gonzalez Olivera, Multidisciplinary Research Center, UNAM-UABJO-Medicine, Mexico City, CP 68050, Mexico

Eduardo Perez-Campos, Laura Perez-Campos Mayoral, Clinical Pathology, Clinical Pathology Laboratory “Dr. Eduardo Perez Ortega”, Oaxaca, CP 68000, Mexico

Javier Arjona Perez, Aurora Clinic, Neurosurgery, Oaxaca, CP 68000, Mexico

Itandehui Gallegos Velasco, Pedro Hernandez Cruz, Laboratory of Cancer Glycobiology, Multidisciplinary Research Center, UNAM-UABJO-Medicine, Mexico City, CP 68050, Mexico

Primitivo Gonzalez Olivera, Surgical Oncology, Puebla Mexico, CP 72000, Mexico

Author contributions: Perez-Campos E and Perez-Campos Mayoral L supervised and wrote equally to this work; Arjona-Pérez J, Gallegos Velasco I, Hernandez Cruz P and Gonzalez Olivera P discussed and rewrote the manuscript.

Correspondence to: Eduardo Perez-Campos, PhD, Researcher, Department of Biochemistry and Immunology, Technological Institute of Oaxaca, Zaragoza 213, Oaxaca, CP 68030, Mexico. perezcampos@prodigy.net.mx

Telephone: +52-951-5161140 Fax: +52-951-5140005

Received: June 28, 2013
Revised: October 28, 2013
Accepted: November 7, 2013
Published online: November 20, 2013

Core Tip

Core tip: It is necessary to reconsider the treatment of elderly patients with glioma, focusing on their life quality when conventional treatment is used, such as, chemotherapy and radiotheraphy, in review of the fact that these treatments cause the patient further suffering. This is a review of othe therapeutic options, including some phase I vaccine trials.